---
title: "Rinvoq (upadacitinib) in rheumatoid arthritis: Access and coverage questions"
description: "Access and coverage questions on Rinvoq (upadacitinib) in rheumatoid arthritis, each answered with verbatim quotes from the manufacturer's US website for healthcare professionals or documents it links. Topics: Access and billing, Access and support, Cost and coverage, Prior authorization, and Patient support. Questions: What is the NDC for RINVOQ 15 mg tablets? Is RINVOQ covered by insurance and Medicare Part D for rheumatoid arthritis? Is there a RINVOQ copay assistance program? How much does RINVOQ cost with copay assistance? 8 further questions follow. 12 questions quoted from 5 sources."
canonical: "https://www.evicenter.com/medical-information/rinvoq--rheumatoid-arthritis/access-and-coverage"
published: "2026-11-12T22:05:36-05:00"
modified: "2026-11-14T01:54:55-05:00"
---

# Rinvoq (upadacitinib) in rheumatoid arthritis: Access and coverage questions

Manufacturer: AbbVie Inc.  
Prescribing information: [Rinvoq](https://www.rinvoqhcp.com/prescribinginfo)

## Access and billing

<a id="rinvoq-ndc"></a>

### What is the NDC for RINVOQ 15 mg tablets?

> “• 15 mg: purple, biconvex oblong, with dimensions of 14 x 8 mm, and debossed with ‘a15’ 
> on one side.  
> 30 tablets in a bottle; NDC: 0074-2306-30”

Source: [RINVOQ: Prescribing information, page 75, captured 2026-11-08](https://www.rinvoqhcp.com/prescribinginfo#page=75)

## Access and support

<a id="rinvoq-ra-coverage"></a>

### Is RINVOQ covered by insurance and Medicare Part D for rheumatoid arthritis?

> “Payers cover RINVOQ after the trial of 1 TNFi (branded or biosimilar) with ~99% PREFERRED combined commercial and Medicare Part D coverage<sup>||¶</sup>
>
> National commercial and Medicare Part D formulary coverage under the pharmacy benefit as of April 2026”

Source: [RINVOQ: RINVOQ® (upadacitinib) for Rheumatoid Arthritis, captured 2026-11-08](https://www.rinvoqhcp.com/rheumatoid-arthritis#:~:text=Payers%20cover%20RINVOQ%20after%20the,benefit%20as%20of%20April%202026)

> “RINVOQ is on a preferred tier or otherwise has preferred status on the plan’s formulary.
>
> <sup>¶</sup>Coverage requirements and benefit designs vary by payer and may change over time. Please consult with payers directly for the most current reimbursement policies.”

Source: [RINVOQ: RINVOQ® (upadacitinib) for Rheumatoid Arthritis, captured 2026-11-08](https://www.rinvoqhcp.com/rheumatoid-arthritis#:~:text=RINVOQ%20is%20on%20a%20preferred,the%20most%20current%20reimbursement%20policies.)

<a id="rinvoq-copay-savings"></a>

### Is there a RINVOQ copay assistance program?

> “Your eligible, commercially insured patients may pay as little as $0 per month with the RINVOQ Complete Savings Card.<sup>§</sup>”

Source: [RINVOQ: RINVOQ® (upadacitinib) Access for RA, PsA, AS, nr-axSpA, and GCA, captured 2026-11-13](https://www.rinvoqhcp.com/rheumatology/access#:~:text=Your%20eligible%2C%20commercially%20insured%20patients,with%20the%20RINVOQ%20Complete%20Savings)

> “<sup>§</sup>RINVOQ Complete Savings Card Terms and Conditions Eligibility: Available to patients with commercial insurance coverage for RINVOQ<sup>®</sup> (upadacitinib) who meet eligibility criteria. This co-pay assistance program is not available to patients receiving prescription reimbursement under any federal, state, or government-funded insurance programs (for example, Medicare [including Part D], Medicare Advantage, Medigap, Medicaid, TRICARE, Department of Defense, or Veterans Affairs programs) or where prohibited by law. Offer subject to change or termination without notice. Restrictions, including monthly maximums, may apply. This is not health insurance. For full Terms and Conditions, visit RINVOQSavingsCard.com or call 1.800.2RINVOQ for additional information.”

Source: [RINVOQ: RINVOQ® (upadacitinib) Access for RA, PsA, AS, nr-axSpA, and GCA, captured 2026-11-13](https://www.rinvoqhcp.com/rheumatology/access#:~:text=Complete%20Savings%20Card%20Terms%20and,call%201.800.2RINVOQ%20for%20additional%20information.)

<a id="rinvoq-insurance-delay-no-charge"></a>

### Can commercially insured patients get RINVOQ at no charge during a coverage denial?

> “No charge for eligible patients experiencing initial insurance denial for up to 24 months.<sup>†</sup>”

Source: [RINVOQ: RINVOQ® (upadacitinib) Complete Patient Support, captured 2026-11-13](https://www.rinvoqhcp.com/patient-support#:~:text=No%20charge%20for%20eligible%20patients,denial%20for%20up%20to%2024)

> “<sup>†</sup>Eligibility criteria: Available to patients aged 63 or younger with commercial insurance coverage. Patients must have a valid prescription for RINVOQ<sup>®</sup> (upadacitinib) for an FDA approved indication and a denial of insurance coverage based on a prior authorization request on file along with a confirmation of appeal. Continued eligibility for the program requires the submission of an appeal of the coverage denial every 180 days. Program provides for RINVOQ at no charge to patients for up to two years or until they receive insurance coverage approval, whichever occurs earlier, and is not contingent on purchase requirements of any kind. Program is not available to patients whose medications are reimbursed in whole or in part by Medicare, Medicaid, TRICARE, or any other federal or state program. Offer subject to change or discontinuance without notice. This is not health insurance and program does not guarantee insurance coverage. No claims for payment may be submitted to any third party for product dispensed by program. Limitations may apply.”

Source: [RINVOQ: RINVOQ® (upadacitinib) Complete Patient Support, captured 2026-11-13](https://www.rinvoqhcp.com/patient-support#:~:text=criteria%3A%20Available%20to%20patients%20aged,by%20program.%20Limitations%20may%20apply.)

<a id="rinvoq-lab-test-reimbursement"></a>

### Does RINVOQ Complete reimburse lab test costs for commercially insured patients?

> “Eligible, commercially insured patients may pay as little as $0 per month on their RINVOQ prescription and can be reimbursed for the out-of-pocket costs of related lab tests and monitoring.*”

Source: [RINVOQ: RINVOQ® (upadacitinib) Complete Patient Support, captured 2026-11-13](https://www.rinvoqhcp.com/patient-support#:~:text=Eligible%2C%20commercially%20insured%20patients%20may,related%20lab%20tests%20and%20monitoring.%2A)

> “*Eligibility: Available to patients with commercial insurance coverage for RINVOQ who meet eligibility criteria. This co-pay assistance program is not available to patients receiving prescription reimbursement under any federal, state, or government-funded insurance programs (for example, Medicare [including Part D], Medicare Advantage, Medigap, Medicaid, TRICARE, Department of Defense, or Veterans Affairs programs) or where prohibited by law. Offer subject to change or termination without notice. Restrictions, including monthly maximums, may apply. This is not health insurance.”

Source: [RINVOQ: RINVOQ® (upadacitinib) Complete Patient Support, captured 2026-11-13](https://www.rinvoqhcp.com/patient-support#:~:text=%2AEligibility%3A%20Available%20to%20patients%20with,This%20is%20not%20health%20insurance.)

<a id="rinvoq-field-reimbursement-manager"></a>

### Who helps prescribers with RINVOQ reimbursement and access questions?

> “Your Field Reimbursement Manager (FRM) is your primary contact to provide education and support related to access and reimbursement questions and activities. FRMs have expertise in Complete access resources and can help build confidence in navigating an ever-changing access landscape.”

Source: [RINVOQ: RINVOQ® (upadacitinib) Complete Patient Support, captured 2026-11-13](https://www.rinvoqhcp.com/patient-support#:~:text=Your%20Field%20Reimbursement%20Manager%20%28FRM%29,navigating%20an%20ever%2Dchanging%20access%20landscape.)

> “When you enroll patients at the time of prescription
> provides you with a dedicated field reimbursement
> manager and supports you throughout the prescription journey
>
> Dedicated Point of Contact:
> Field Reimbursement Managers help you and your patients navigate access—with case-by-case, personalized support to prevent delays and denials.”

Source: [RINVOQ: RINVOQ® (upadacitinib) Access for RA, PsA, AS, nr-axSpA, and GCA, captured 2026-11-13](https://www.rinvoqhcp.com/rheumatology/access#:~:text=When%20you%20enroll%20patients%20at,to%20prevent%20delays%20and%20denials.)

Note: On the access page, the RINVOQ Complete logo stands between 'When you enroll patients at the time of prescription' and 'provides you with a dedicated field reimbursement manager'.

<a id="rinvoq-specialty-pharmacy"></a>

### How are RINVOQ prescriptions sent to a specialty pharmacy?

> “You may also complete
> the Pharmacy Prescription Form and fax it to your patient's specialty pharmacy”

Source: [RINVOQ: RINVOQ® (upadacitinib) Complete Patient Support, captured 2026-11-13](https://www.rinvoqhcp.com/patient-support#:~:text=You%20may%20also%20complete,to%20your%20patient%27s%20specialty%20pharmacy)

> “With CompletePro.com, you can:
>
> Request benefits verifications
> Complete and submit prior authorizations
> Send prescriptions to the patient’s specialty pharmacy of choice, with the option to include a savings card for eligible patients”

Source: [RINVOQ: RINVOQ® (upadacitinib) Complete Patient Support, captured 2026-11-13](https://www.rinvoqhcp.com/patient-support#:~:text=With%20CompletePro.com%2C%20you%20can%3A,savings%20card%20for%20eligible%20patients)

## Cost and coverage

<a id="rinvoq-copay-cost"></a>

### How much does RINVOQ cost with copay assistance?

> “Eligible, commercially insured 
> patients may pay as little as $0 
> per month on their prescription”

Source: [RINVOQ: Dosing Guide, page 4, captured 2026-11-08](https://www.rinvoqhcp.com/content/dam/rinvoqhcpivy/docs/rheumatology-dosing-guide.pdf#page=4)

> “Eligibility: Available to patients with commercial insurance coverage for RINVOQ® 
> (upadacitinib) who meet eligibility criteria. This co-pay assistance program is not available 
> to patients receiving prescription reimbursement under any federal, state, or 
> government-funded insurance programs (for example, Medicare [including Part D], 
> Medicare Advantage, Medigap, Medicaid, TRICARE, Department of Defense, or Veterans 
> Affairs programs) or where prohibited by law. Offer subject to change or termination 
> without notice. Restrictions, including monthly maximums, may apply. This is not health 
> insurance.”

Source: [RINVOQ: Dosing Guide, page 4, captured 2026-11-08](https://www.rinvoqhcp.com/content/dam/rinvoqhcpivy/docs/rheumatology-dosing-guide.pdf#page=4)

<a id="rinvoq-commercial-out-of-pocket"></a>

### What share of commercial RINVOQ claims cost patients $0?

> “96<sup>%</sup>
> of commercial claims for a filled
> RINVOQ prescription cost patients<sup>5‡</sup>
> $0”

Source: [RINVOQ: RINVOQ® (upadacitinib) Access for RA, PsA, AS, nr-axSpA, and GCA, captured 2026-11-13](https://www.rinvoqhcp.com/rheumatology/access#:~:text=of%20commercial%20claims%20for%20a,%240)

> “<sup>‡</sup>Based upon paid commercial claims data from national data providers for a filled RINVOQ prescription for RA, PsA, AS, nr-axSpA, and GCA for the period 5/2025-4/2026, inclusive of savings card redemptions.<sup>5</sup>
>
> Patient’s actual out-of-pocket cost may vary depending on their insurance coverage and eligibility for support programs.”

Source: [RINVOQ: RINVOQ® (upadacitinib) Access for RA, PsA, AS, nr-axSpA, and GCA, captured 2026-11-13](https://www.rinvoqhcp.com/rheumatology/access#:~:text=upon%20paid%20commercial%20claims%20data,and%20eligibility%20for%20support%20programs.)

<a id="rinvoq-medicare-part-d-cost"></a>

### How much does RINVOQ cost with Medicare Part D?

> “As a standard Medicare Part D patient enrolled in the Medicare Prescription Payment Plan, Cheryl pays $200 per month for all her prescriptions.<sup>6</sup>”

Source: [RINVOQ: RINVOQ® (upadacitinib) Access for RA, PsA, AS, nr-axSpA, and GCA, captured 2026-11-13](https://www.rinvoqhcp.com/rheumatology/access#:~:text=As%20a%20standard%20Medicare%20Part,per%20month%20for%20all%20her)

> “As a Medicare Part D Extra Help patient, Joey pays $14.40 per prescription for RINVOQ.<sup>6</sup>”

Source: [RINVOQ: RINVOQ® (upadacitinib) Access for RA, PsA, AS, nr-axSpA, and GCA, captured 2026-11-13](https://www.rinvoqhcp.com/rheumatology/access#:~:text=As%20a%20Medicare%20Part%20D,pays%20%2414.40%20per%20prescription%20for)

> “Final patient out-of-pocket costs may vary based on a number of factors, including but not limited to a patient's insurance coverage,
> plan design, and Medicare Extra Help qualified enrollment.”

Source: [RINVOQ: RINVOQ® (upadacitinib) Access for RA, PsA, AS, nr-axSpA, and GCA, captured 2026-11-13](https://www.rinvoqhcp.com/rheumatology/access#:~:text=Final%20patient%20out%2Dof%2Dpocket%20costs%20may,Medicare%20Extra%20Help%20qualified%20enrollment.)

> “Announcement of calendar year (CY) 2027 Medicare Advantage (MA) capitation rates and Part C and Part D payment policies. Centers for Medicare & Medicaid Services. April 6, 2026. Accessed September 17, 2026. https://www.cms.gov/files/document/2027-announcement.pdf”

Source: [RINVOQ: RINVOQ® (upadacitinib) Access for RA, PsA, AS, nr-axSpA, and GCA, captured 2026-11-13](https://www.rinvoqhcp.com/rheumatology/access#:~:text=Announcement%20of%20calendar%20year%20%28CY%29,Accessed%20September%2017%2C%202026.%20https%3A%2F%2Fwww.cms.gov%2Ffiles%2Fdocument%2F2027%2Dannouncement.pdf)

Note: The page presents Cheryl and Joey as example patients; both figures cite the page's sixth reference, the CMS announcement of 2027 Part D payment policies, quoted last.

## Prior authorization

<a id="rinvoq-prior-authorization-online"></a>

### Can RINVOQ prior authorizations be submitted online?

> “CompletePro.com enables seamless enrollment into RINVOQ Complete and helps smooth the prescription process for your patients.
>
> With CompletePro.com, you can:
>
> Request benefits verifications
> Complete and submit prior authorizations
> Send prescriptions to the patient’s specialty pharmacy of choice, with the option to include a savings card for eligible patients
> Receive alerts for annual reauthorizations and renewals”

Source: [RINVOQ: RINVOQ® (upadacitinib) Complete Patient Support, captured 2026-11-13](https://www.rinvoqhcp.com/patient-support#:~:text=CompletePro.com%20enables%20seamless%20enrollment%20into,for%20annual%20reauthorizations%20and%20renewals)

## Patient support

<a id="rinvoq-complete-enrollment"></a>

### How do you enroll a patient in RINVOQ Complete?

> “How to Enroll Patients in RINVOQ Complete
>
> Download
> and fill out the RINVOQ Complete Enrollment and Prescription Form with your patient
>
> After submitting
> the form via fax, your patient will receive a call from an Ambassador*”

Source: [RINVOQ: RINVOQ® (upadacitinib) Complete Patient Support, captured 2026-11-13](https://www.rinvoqhcp.com/patient-support#:~:text=How%20to%20Enroll%20Patients%20in,a%20call%20from%20an%20Ambassador%2A)

> “*Ambassadors are provided by AbbVie and do not provide medical advice or work under the direction of the prescribing healthcare professional (HCP). They are trained to direct patients to speak with their HCP about any treatment-related questions, including further referrals.”

Source: [RINVOQ: RINVOQ® (upadacitinib) Complete Patient Support, captured 2026-11-13](https://www.rinvoqhcp.com/patient-support#:~:text=%2AAmbassadors%20are%20provided%20by%20AbbVie,treatment%2Drelated%20questions%2C%20including%20further%20referrals.)

> “Have questions or need support over the phone?
>
> Call 1.877.COMPLETE (1.877.266.7538)”

Source: [RINVOQ: RINVOQ® (upadacitinib) Complete Patient Support, captured 2026-11-13](https://www.rinvoqhcp.com/patient-support#:~:text=Have%20questions%20or%20need%20support,Call%201.877.COMPLETE%20%281.877.266.7538%29)

Note: The page links separate Rheumatology, Dermatology, and Gastroenterology versions of the enrollment form.

## Related pages
- [Medical information: Rinvoq (upadacitinib): Rheumatoid arthritis](https://www.evicenter.com/medical-information/rinvoq--rheumatoid-arthritis)
- [Indication](https://www.evicenter.com/medical-information/rinvoq--rheumatoid-arthritis/indication)
- [Pharmacology](https://www.evicenter.com/medical-information/rinvoq--rheumatoid-arthritis/pharmacology)
- [Clinical trials](https://www.evicenter.com/medical-information/rinvoq--rheumatoid-arthritis/clinical-trials)
- [Safety](https://www.evicenter.com/medical-information/rinvoq--rheumatoid-arthritis/safety)
- [Specific populations](https://www.evicenter.com/medical-information/rinvoq--rheumatoid-arthritis/specific-populations)
- [Drug interactions](https://www.evicenter.com/medical-information/rinvoq--rheumatoid-arthritis/drug-interactions)
- [Dosing and administration](https://www.evicenter.com/medical-information/rinvoq--rheumatoid-arthritis/dosing-and-administration)
- [Storage and supply](https://www.evicenter.com/medical-information/rinvoq--rheumatoid-arthritis/storage-and-supply)
